Rathbones Group’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,721	Closed	-$7.16K	–	640
2024 Q4	$7.16K	Buy	6,721 +6,161	+1,100%	+$6.56K	﹤0.01%	605
2024 Q3	$6.21K	Hold	560	–	–	﹤0.01%	602
2024 Q2	$5.2K	Hold	560	–	–	﹤0.01%	614
2024 Q1	$18.3K	Hold	560	–	–	﹤0.01%	607
2023 Q4	$15K	Hold	560	–	–	﹤0.01%	607
2023 Q3	$33.9K	Buy	560 +4	+0.7%	+$242	﹤0.01%	603
2023 Q2	$56.6K	Hold	556	–	–	﹤0.01%	400
2023 Q1	$98.2K	Hold	556	–	–	﹤0.01%	392
2022 Q4	$215K	Hold	556	–	–	﹤0.01%	369
2022 Q3	$187K	Hold	556	–	–	﹤0.01%	376
2022 Q2	$183K	Hold	556	–	–	﹤0.01%	392
2022 Q1	$243K	Hold	556	–	–	﹤0.01%	377
2021 Q4	$244K	Hold	556	–	–	﹤0.01%	382
2021 Q3	$309K	Buy	556 +167	+43%	+$92.8K	﹤0.01%	350
2021 Q2	$200K	Sell	389 -139	-26%	-$71.5K	﹤0.01%	401
2021 Q1	$412K	Hold	528	–	–	0.01%	309
2020 Q4	$287K	Hold	528	–	–	﹤0.01%	335
2020 Q3	$242K	Hold	528	–	–	﹤0.01%	330
2020 Q2	$325K	Hold	528	–	–	0.01%	281
2020 Q1	$251K	Hold	528	–	–	0.01%	265
2019 Q4	$306K	Hold	528	–	–	0.01%	271
2019 Q3	$347K	Buy	528 +56	+12%	+$36.8K	0.01%	266
2019 Q2	$366K	Hold	472	–	–	0.01%	250
2019 Q1	$334K	Buy	472 +28	+6%	+$19.8K	0.01%	255
2018 Q4	$208K	Buy	444 +180	+68%	+$84.3K	0.01%	287
2018 Q3	$228K	Buy	+264	New	+$228K	0.01%	272
2017 Q3	–	Sell	-333	Closed	-$185K	–	326
2017 Q2	$185K	Buy	+333	New	+$185K	0.01%	288